MANF/CK19轴在肝细胞向胆管癌转分化中的调控作用OA
Regulatory role of the mesencephalic astrocyte-derived neurotrophic factor/cytokeratin 19 axis in hepatocyte-to-cholangiocarcinoma transdifferentiation
目的 探讨星形胶质细胞源性神经营养因子(MANF)/细胞角蛋白19(CK19)轴在肝细胞向胆管癌样表型转分化中的调控作用.方法 采用硫代乙酰胺(TAA)诱导建立小鼠肝内胆管癌(ICC)模型.将小鼠随机分为正常对照组(Con组)、模型组(Model组)、肝特异性MANF敲除组(HKO组)和重组人MANF干预组(rhMANF组),每组12只.检测各组小鼠血清肝功能指标(丙氨酸氨基转移酶(ALT)、天冬氨酸氨基转移酶(AST)、总胆红素(TBIL)和直接胆红素(DBIL))及MANF水平;采用实时荧光定量聚合酶链反应(qRT-PCR)法、免疫组化染色及免疫荧光染色检测肝组织中MANF与CK19的表达.分离原代肝细胞,将细胞随机分为BSA对照组与rhMANF处理组,观察细胞形态,并采用蛋白质印迹(Western blot)法检测MANF、CK19、肝细胞核因子4α(HNF4α)蛋白表达变化;采用免疫共沉淀(Co-IP)检测MANF与CK19的相互作用.结果 与Con组比较,Model组小鼠血清ALT、AST、TBIL、DBIL 及 MANF 水平增高,肝组织 MANF、CK19 mRNA 和蛋白表达升高(F=192.48~394.69,P<0.001);HKO组上述指标低于Model组,rhMANF组高于HKO组,差异均有统计学意义(P<0.05).体外实验结果显示,与BSA组比较,rhMANF组原代肝细胞呈现胆管样形态改变,MANF与CK19蛋白表达升高,HNF4α蛋白表达降低(t=8.97~28.92,P<0.001).免疫荧光染色显示,MANF与CK19存在共定位,免疫共沉淀进一步证实二者存在相互作用.结论 MANF可能通过与CK19相互作用,协同下调HNF4α,驱动肝细胞获得胆管样表型,该轴可能是参与ICC发生发展的重要分子通路之一.
Objective To investigate the regulatory role of the mesencephalic astrocyte-derived neurotrophic factor(MANF)/cytokeratin 19(CK19)axis in hepatocyte-to-cholangiocarcinoma-like phenotypic transdifferentiation.Methods The method of thioacetamide(TAA)induction was used to establish a mouse model of intrahepatic cholangiocarcinoma(ICC).Mice were randomly divided into normal control group(Con group),Model group,hepatocyte-specific MANF knockout group(HKO group),and recombinant human MANF intervention group(rhMANF group),with 12 mice in each group.Serum liver function parameters(alanine aminotransferase[ALT],aspartate aminotransferase[AST],total bilirubin[TBIL],and direct bilirubin[DBIL])and MANF were measured,and qRT-PCR,immunohistochemical staining,and immunofluorescent staining were used to measure the expression levels of MANF and CK19 in liver tissue.Primary hepatocytes were isolated and randomly divided into BSA control group and rhMANF treatment group.Cell morphology was observed;Western blot was used to measure the changes in the protein expression levels of MANF,CK19,and hepatocyte nuclear factor 4α(HNF4α);co-immunoprecipitation(Co-IP)was used to observe the interaction between MANF and CK19.Results Compared with the Con group,the Model group had significant increases in the serum levels of ALT,AST,TBIL,DBIL,and MANF and the mRNA and protein expression levels of MANF and CK19 in liver tissue(F=192.48-394.69,P<0.001).The HKO group had significantly lower levels of the above indicators com-pared with the Model group,while the rhMANF group had significantly higher levels of these indicators compared with the HKO group(P<0.05).In vitro experiments showed that compared with the BSA group,the rhMANF group showed cholangiocyte-like morphological changes of primary hepatocytes,significant increases in the protein expression levels of MANF and CK19,and a significant reduction in the protein expression level of HNF4α(t=8.97-28.92,P<0.001).Immunofluorescent staining showed the colocalization of MANF and CK19,and Co-IP further confirmed the interaction between MANF and CK19.Conclusion MANF may drive hepatocytes to acquire a cholangiocyte-like phenotype by interacting with CK19 and synergistically downregulating HNF4α,suggesting that this axis may be one of the important mole-cular pathways involved in the development and progression of ICC.
胡炜;刘晗;郝智楠;刘思佚;张庆
长江大学附属第一医院消化内科,湖北荆州 434000||重庆市九龙坡区人民医院消化内科重庆市九龙坡区人民医院消化内科长江大学附属第一医院消化内科,湖北荆州 434000四川省成都市第六人民医院医学检验科长江大学附属第一医院消化内科,湖北荆州 434000
医药卫生
胶质细胞源性神经营养因子角蛋白19胆管肿瘤肝细胞细胞转分化
glial cell line-derived neurotrophic factorkeratin-19bile duct neoplasmshepatocytescell transdifferentiation
《青岛大学学报(医学版)》 2026 (3)
385-392,8
重庆市自然科学基金面上项目(CSTB2024-NSCQ-MSX0251)
评论